AstraZeneca PLC (AZN.L)
LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:35PM BST
| Previous Close | 12,404.00 |
| Open | 12,334.00 |
| Bid | 12,318.00 x 0 |
| Ask | 12,364.00 x 0 |
| Day's Range | 12,244.00 - 12,442.00 |
| 52 Week Range | 9,461.00 - 12,488.00 |
| Volume | |
| Avg. Volume | 2,599,484 |
| Market Cap | 190.618B |
| Beta (5Y Monthly) | 0.16 |
| PE Ratio (TTM) | 38.55 |
| EPS (TTM) | 3.19 |
| Earnings Date | Jul 25, 2024 |
| Forward Dividend & Yield | 2.28 (1.84%) |
| Ex-Dividend Date | Feb 22, 2024 |
| 1y Target Est | 129.34 |
ZacksPharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
Simply Wall St.Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Business WireAstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
WILMINGTON, Del., May 23, 2024--AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RWE), from their portfolio and pipeline of investigational amyloidosis therapies at the International Symposium on Amyloidosis (ISA), in Rochester, MN from May 26–30, 2024.
© 2024 Yahoo. All rights reserved.